RWD
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
MORSE's Sang Mi Lee joins a podcast with Exactis Innovation discussing the intricacies of Canada's drug reimbursement system and how it might evolve with the recent creation of the Canadian Drug Agency (CDA). Summary: With national pharmacare closer to reality in Canada, our insightful conversation with market access professionals and seasoned pharmacists, Sang Mi Lee, MBA, BSc Phm, RPh and Brian O’Rourke, sheds light on the intricacies of Canada’s drug reimbursement system…
At MORSE Consulting, we're delighted to share insights from Sherry O'Quinn's recent participation at the Rare Disease Day 2024 Summit held by the Canadian Organization for Rare Disorders (CORD) in Ottawa. The conference, themed around sustaining the momentum of two decades of impactful work in the rare disease community, was insightful and inspiring. Sherry had the opportunity to present a snapshot on the timelines to access for drugs for…
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
September 14, 2023 - We are thrilled to announce a groundbreaking collaboration between MORSE Consulting and Medlior Health Outcomes Research, two leaders in the Canadian pharmaceutical market access landscape. This partnership aims to blend MORSE Consulting's unparalleled expertise in payer and HTA strategies with Medlior's cutting-edge real-world evidence solutions, offering our clients an unmatched array of services to navigate the complex world of pharmaceutical market access. MORSE Consulting is a…
Introduction The Canadian Association for Healthcare Reimbursement (CAHR) held its first virtual Market Access 201 conference on November 24, 2020. Members of the MORSE team attended this conference and have prepared a brief summary of the key highlights. Disclaimer: Please note, this summary is based on our team’s interpretation of the discussion. Session 1. Keynote: Evolution of HTA in United States and the Impact on International Markets …
The 2019 Real-World Evidence and Outcomes-Based Agreements Working Group research and outputs executive summary report is now available. The mission of the Real-World Evidence and Outcomes-Based Agreements Working Group is to advance the opportunity for the use of outcomes-based agreements in Canada.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
RWD - Info and details on - MORSE Consulting Inc.